MindMed Revenue and Competitors
Estimated Revenue & Valuation
- MindMed's estimated annual revenue is currently $16.9M per year.
- MindMed's estimated revenue per employee is $155,000
Employee Data
- MindMed has 109 Employees.
- MindMed grew their employee count by 11% last year.
MindMed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Accounting Officer | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Accounting Officer | Reveal Email/Phone |
4 | VP Pharmaceutical Development | Reveal Email/Phone |
5 | VP, Global Regulatory Affairs | Reveal Email/Phone |
6 | VP, Head Development | Reveal Email/Phone |
7 | VP, Programs | Reveal Email/Phone |
8 | VP, Global Market Access Pricing and HEOR | Reveal Email/Phone |
9 | VP Programs and Portfolio Office | Reveal Email/Phone |
10 | VP, Global Operations | Reveal Email/Phone |
MindMed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $8.8M | 121 | 12% | N/A | N/A |
#2 | $11.3M | 73 | 7% | N/A | N/A |
#3 | $6040M | 28609 | 5% | $1.5B | $3.3B |
#4 | $7.5M | 90 | 53% | N/A | N/A |
#5 | $16.9M | 109 | 11% | N/A | N/A |
What Is MindMed?
MindMed is a psychedelic medicine biotech company that discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT and an Ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to the company's groundbreaking approach to developing the next-generation of psychedelic inspired medicines and therapies. MindMed trades on the Canadian exchange NEO under the symbol MMED. MindMed is also traded in the United States under the symbol MMEDF and in Germany under the symbol MMQ. For more information: www.mindmed.co
keywords:N/A
N/A
Total Funding
109
Number of Employees
$16.9M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MindMed News
MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on...
MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.8M | 109 | -10% | $42M |
#2 | $22.9M | 109 | -6% | N/A |
#3 | $3.5M | 109 | 21% | N/A |
#4 | $15.8M | 109 | -2% | $53.6M |
#5 | $7.5M | 109 | 7% | N/A |